Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 16th Street, 4th floor
San Francisco, CA 94143Phone+1 415-476-3892
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2015
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2015
- Children's Hospital-OaklandChief Residency, Pediatrics, 2012 - 2013
- Children's Hospital-OaklandResidency, Pediatrics, 2008 - 2011
- Northwestern University The Feinberg School of MedicineClass of 2008, MD/MPH
Certifications & Licensure
- CA State Medical License 2010 - 2025
- MA State Medical License 2012 - 2018
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection Start of enrollment: 2020 Jul 07
Roles: Contact
- Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) Start of enrollment: 2020 Jul 01
Roles: Contact
- Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection Start of enrollment: 2018 Nov 01
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsHematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiencyWaleed Al-Herz, Julia I. Chu, Jet van der Spek, Raj Raghupathy, Michel J. Massaad
The Journal of Allergy and Clinical Immunology. 2016-09-01 - 8 citationsOutcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.Roxane Labrosse, Julia I Chu, Myriam A Armant, John K Everett, Danilo Pellin
Blood. 2023-10-12 - 16 citationsA pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients.Christine S Higham, Kristin A Shimano, Alexis Melton, Sandhya Kharbanda, Julia Chu
Pediatric Blood & Cancer. 2022-05-01
Professional Memberships
- Member
- American Society of Pediatric Hematology/OncologyMember
- American Society for Blood and Marrow TransplantationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: